)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
AIM ImmunoTech
AIM ImmunoTech (AIM) investor relations material
AIM ImmunoTech Virtual Investor Closing Bell summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Virtual Investor Closing Bell summary19 Feb, 2026
Strategic focus and rationale
Ampligen's development is now prioritized for pancreatic cancer due to its high lethality, rapid progression, and significant unmet medical need, with over 450,000 deaths worldwide annually.
Ampligen has shown positive data in multiple solid tumors, but pancreatic cancer was chosen for its market size, lack of effective therapies, and moral imperative.
Orphan drug designations in the US and EU provide market exclusivity post-approval, enhancing the business case.
Intellectual property and collaborations with industry and government support the program's advancement.
The business model aims for acquisition or licensing by a major pharmaceutical company after Phase 3 readiness.
Clinical progress and data
Over 75 subjects have been treated in pancreatic cancer studies, with strong safety and efficacy data.
Ampligen extends median overall survival by more than eight months compared to historical controls, with improved quality of life.
The drug is well-tolerated and restores immune function, countering the immunosuppression caused by chemotherapy.
Biomarkers such as CA19-9 and neutrophil/lymphocyte ratios help identify strong responders and inform trial design.
Phase 2 is nearing completion, with primary and secondary endpoint data expected within the next year.
Mechanism of action and differentiation
Ampligen activates Toll-like 3 receptors in epithelial tumors, converting immune-silent (cold) tumors into immune-active (hot) tumors.
Functions as both monotherapy and in combination with checkpoint inhibitors, enhancing their effectiveness.
Demonstrated synergy with Keytruda in ovarian and triple-negative breast cancer trials.
The immune system boost from Ampligen reduces infections and comorbidities in immunosuppressed patients.
The approach offers a broad platform potential for other solid tumors beyond pancreatic cancer.
Orphan drug impact on market exclusivity?
Ampligen's unique role in cold tumors
Phase 3 design's role in big pharma deals
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next AIM ImmunoTech earnings date
Q4 202531 Mar, 2026
AIM ImmunoTech
Next AIM ImmunoTech earnings date
Q4 202531 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma, Inc., is an immuno-pharmaceutical company dedicated to the research and development of therapeutics for the treatment of multiple types of cancers, viral diseases, and immune-deficiency disorders. The company's leading product candidate is Ampligen, a drug composed of macromolecular ribonucleic acid molecules aimed at treating chronic fatigue syndrome (CFS). Ampligen is also under development for various cancer types, including renal cell carcinoma, malignant melanoma, and others, as well as for conditions like Hepatitis B, HIV, COVID-19, and post-COVID conditions. Another key product is Alferon N Injection, an injectable formulation of natural alpha interferon for treating human papillomavirus (HPV) and genital warts. The company is headquartered in Ocala, Florida, and its shares are listed on the NYSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage